Indeed, orally administered EPA was shown to markedly ameliorate special diet-induced AD-like symptoms in hairless mice accompanied by attenuated TSLP, IL-4, and IL-5, along with improved skin barrier function [78]. This evidence concerns the gene IL5 and Alzheimer disease.